IL-7 earns her ticket in allo-HSCT

Blood

Volumn 120, Issue 24, 2012, Pages 4669-4770

  Toubert, Antoine ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 22; INTERLEUKIN 7 RECEPTOR; RECOMBINANT INTERLEUKIN 7; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; CANCER PATIENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DRUG SAFETY; EFFECTOR CELL; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPROMISED PATIENT; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTOPENIA; MEMORY CELL; MEMORY T LYMPHOCYTE; NONHUMAN; NOTE; PERIPHERAL T CELL LYMPHOMA; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS;

EID: 84870743190     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-10-460386     Document Type: Note

References (9)

1. Perales MA, Goldberg JD, Yuan J, et al. Recombinant human interleukin-7 (CYT107) promotes Tcell recovery after allogeneic stem cell transplantation. Blood. 2012; 120(24):4882-4891.
2. Toubert A, Glauzy S, Douay C, Clave E. Thymus and immune reconstitution after allogeneic stem cell transplantation in humans: never say never again. Tissue Antigens. 2012;79(2):83-89.
3. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 2011; 11(5):330-342.
4. Sportès C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR répertoire diversity by preferential expansion of naïve Tcell subsets. J Exp Med. 2008;205(7):1701-1714. (Pubitemid 351962032)
5. Lévy Y, Sereti I, Tambussi G, et al. Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antirétroviral therapy: results of a phase I/Iia randomized, placebocontrolled, multicenter study. Clin Infect Dis. 2012;55(2): 291-300.
6. Sinha ML, Fry TJ, Fowler DH, Miller G, Mackall CL. Interleukin 7 worsens graft-versus-host disease. Blood. 2002;100(7):2642-2649.
7. Spits H, Di Santo J. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Rev Immunol. 2011;12(1):21-27.
8. Hanash AM, Dudakov JA, Hua G, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and régulâtes sensitivity to graft versus host disease. Immunity. 2012;37(2):339-350.
9. Dudakov JA, Hanash AM, Jenq RR, et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science. 2012;336(6077):91-95.